Deletion of Hif1a protects against liver fibrosis in mouse models of both fibrotic liver disease, such as mice subjected to BDL (74), and models of NAFLD (56, 77). The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatotic liver disease.